FIELD: biotechnology.
SUBSTANCE: invention relates to biotechnology, in particular to a method for preparing a composition for storage and transportation of mesenchymal stem cells, where said mesenchymal stem cells are mesenchymal stem cells of the amniotic membrane of the umbilical cord. Also disclosed is a composition for storage and transportation of mesenchymal stem cells. Invention also relates to a method for transporting mesenchymal stem cells and to the use of a composition for storing and transporting mesenchymal stem cells for preparing a pharmaceutical composition for treating a subject suffering from a disease, where the disease is a wound.
EFFECT: invention provides efficient storage and transportation of mesenchymal stem cells.
27 cl, 33 dwg, 5 tbl, 9 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR ASSESSING WOUND HEALING POTENTIAL OF POPULATION OF MESENCHYMAL STEM CELLS AND RELATED METHODS FOR SELECTING MESENCHYMAL STEM CELLS AND IDENTIFYING TISSUE AS STARTING MATERIAL FOR PRODUCING POPULATION OF MESENCHYMAL STEM CELLS | 2020 |
|
RU2827447C1 |
| TREATING CANCER USING CHIMERIC ANTIGEN-SPECIFIC RECEPTOR BASED ON HUMANIZED ANTI-EGFRvIII ANTIBODY | 2014 |
|
RU2831418C2 |
| CHIMERIC ANTIGEN RECEPTORS TARGETED B-CELL MATURATION ANTIGEN | 2013 |
|
RU2766608C2 |
| METHODS FOR PRODUCING CELLS EXPRESSING CHIMERIC ANTIGEN RECEPTOR | 2015 |
|
RU2751362C2 |
| CHIMERIC ANTIGENIC (CAR) RECEPTOR AGAINST CD123 FOR USE IN TREATING MALIGNANT TUMORS | 2015 |
|
RU2724999C2 |
| THERAPEUTIC COMPOUNDS AND METHODS | 2016 |
|
RU2770001C2 |
| COMPOSITIONS AND METHODS FOR DEGRADATION OF IMPROPERLY PACKAGED PROTEINS | 2016 |
|
RU2761564C2 |
| COMPOSITIONS AND METHODS FOR SELECTIVE PROTEIN EXPRESSION | 2017 |
|
RU2795467C2 |
| GLYCAN-DEPENDENT IMMUNOTHERAPY MOLECULES | 2016 |
|
RU2754661C2 |
| CENTRAL MEMORY T-CELLS FOR ADOPTIVE T-CELL THERAPY | 2015 |
|
RU2763523C2 |
